Zimmer Biomet Holdings Inc
(LTS:0QQD)
CHF
136.12408
0 (0%)
Market Cap: 18.98 Bil
Enterprise Value: 24.46 Bil
PE Ratio: 19.87
PB Ratio: 1.69
GF Score: 78/100 
Zimmer Biomet Holdings Inc at Raymond James Institutional Investors Conference Transcript
Mar 02, 2020 / 02:50PM GMT
Release Date Price:
CHF147.28
Lawrence Soren Keusch
Raymond James & Associates, Inc., Research Division - MD
Good morning, everyone. Thanks very much for attending the next session. We're extremely, extremely happy to have Zimmer Biomet with us picking up coverage a little over a year ago. So it's extremely exciting for me to have the management here.
We're going to do a full fireside chat rather than a prepared slide presentation. With me to the right is Suky Upadhyay, who's Executive VP and Chief Financial Officer; and to my left is Keri Mattox, who's Senior VP, Investor Relations, and Chief Communications Officer. Keri just joined about, what, middle of January?
Keri P. Mattox
Zimmer Biomet Holdings, Inc. - Senior VP of IR & Chief Communications Officer
Yes.
Lawrence Soren Keusch
Raymond James & Associates, Inc., Research Division - MD
So recent. So thank you, and welcome.
Keri P. Mattox
Zimmer Biomet Holdings, Inc. - Senior VP of IR & Chief Communications Officer
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers